Small_2004_Trends.Neurosci_27_245

Reference

Title : Do acetylcholinesterase inhibitors boost synaptic scaling in Alzheimer's disease? - Small_2004_Trends.Neurosci_27_245
Author(s) : Small DH
Ref : Trends in Neurosciences , 27 :245 , 2004
Abstract :

Studies on neural networks indicate that the pattern of amnesia that occurs in Alzheimer's disease (AD) can be reproduced by synaptic loss, but only when this loss is accompanied by synaptic scaling, a homeostatic mechanism that maintains the level of excitatory input on postsynaptic neurons. It is suggested that increased cholinergic activity during the early stages of AD contributes to synaptic scaling and that acetylcholinesterase inhibitors improve cognition in AD patients by boosting this mechanism.

PubMedSearch : Small_2004_Trends.Neurosci_27_245
PubMedID: 15111005

Related information

Citations formats

Small DH (2004)
Do acetylcholinesterase inhibitors boost synaptic scaling in Alzheimer's disease?
Trends in Neurosciences 27 :245

Small DH (2004)
Trends in Neurosciences 27 :245